Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Marie Alix Poul"'
Autor:
Tracy R. Daniels-Wells, Pierre V. Candelaria, Aileen M. Rodriguez, Marie-Alix Poul, Manuel L. Penichet
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/2a33d8295f3c407abd87e3ee573e5dca
Autor:
Christophe Le Clorennec, Yassamine Lazrek, Olivier Dubreuil, Carla Sampaio, Christel Larbouret, Romain Lanotte, Marie-Alix Poul, Jean-Marc Barret, Jean-François Prost, André Pèlegrin, Thierry Chardès
Publikováno v:
Cell Communication and Signaling, Vol 17, Iss 1, Pp 1-16 (2019)
Abstract Background HER3/ErbB3 receptor deletion or blockade leads to tumor cell apoptosis, whereas its overexpression confers anti-cancer drug resistance through upregulation of protective mechanisms against apoptosis. We produced the anti-HER3 anti
Externí odkaz:
https://doaj.org/article/4b70fcb461494809aa475152be331389
Autor:
Marie-Alix Poul, André Pèlegrin, James D. Marks, Yu Zhou, Yongfeng Fan, Christian Auclair, Madeline Neiveyans, Ronan Crépin, Marianne Le Gall
Materials and methods describing the production of scFv-Fc in HEK-T cells and KIT domains and scFv display on yeast. Table S2: Primers for PCR amplification of KIT and cloning into pYD vector by Gap repair. Figure S1: Selection and initial characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e198400aa10438db5dd6e92282dd1ac
https://doi.org/10.1158/1535-7163.22507152.v1
https://doi.org/10.1158/1535-7163.22507152.v1
Autor:
Thierry Chardès, André Pèlegrin, Jean-François Prost, Gérard Mathis, Jean-Marc Barret, Philippe Mondon, Marie-Alix Poul, Véronique Garambois, Yassamine Lazrek, Charline Ogier, Christel Larbouret, Olivier Dubreuil, Hervé Bazin, Christophe Le Clorennec
Supplemental Fig.S4. High NRG1 level does not affect 9F7-F11-mediated inhibition of cell signaling, whereas it reduces the effect of the ligand-competing anti-HER3 antibody H4B-121. In pancreatic cancer cells, 9F7-F11 and ch9F7-F11 inhibit in a dose-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0165dc7edb2dc1585155dc5b2ae0f63d
https://doi.org/10.1158/1535-7163.22503249
https://doi.org/10.1158/1535-7163.22503249
Autor:
Marie-Alix Poul, André Pèlegrin, James D. Marks, Yu Zhou, Yongfeng Fan, Christian Auclair, Madeline Neiveyans, Ronan Crépin, Marianne Le Gall
Figure S3: Characterization of UT-7/Epo, HMC1.1 and HMC1.2 cell lines. Figure S4: 2D1 and 3G1-Fc do not compete with 104D2 mAb binding to KIT.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0966750bdac5108388badbda58b112
https://doi.org/10.1158/1535-7163.22507155
https://doi.org/10.1158/1535-7163.22507155
Autor:
Marie-Alix Poul, André Pèlegrin, James D. Marks, Yu Zhou, Yongfeng Fan, Christian Auclair, Madeline Neiveyans, Ronan Crépin, Marianne Le Gall
Monitoring of phage antibody selection by titration, ELISA and scFv sequencing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0f5fb8f3dc9a7b23bd08f1950ac172
https://doi.org/10.1158/1535-7163.22507149
https://doi.org/10.1158/1535-7163.22507149
Autor:
Ambre Giguelay, Evgenia Turtoi, Lakhdar Khelaf, Guillaume Tosato, Ikrame Dadi, Tommy Chastel, Marie-Alix Poul, Marine Pratlong, Stefan Nicolescu, Dany Severac, Antoine Adenis, Olivia Sgarbura-Popescu, Sébastien Carrère, Philippe Rouanet, François Quenet, Marc Ychou, Didier Pourqier, Pierre-Emmanuel Colombo, Andrei Turtoi, Jacques Colinge
Publikováno v:
Theranostics. 12(17)
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2019, 35, pp.1083-1091. ⟨10.1051/medsci/2019216⟩
médecine/sciences, EDP Sciences, 2019, 35, pp.1083-1091. ⟨10.1051/medsci/2019216⟩
International audience; Monoclonal antibodies have revolutionized the treatment of many diseases, but their clinical effectiveness remains limited in some cases. Associations of antibodies binding to the same target (homo-combination) or to several d
Publikováno v:
médecine/sciences
médecine/sciences, EDP Sciences, 2019, 35, pp.1083-1091. ⟨10.1051/medsci/2019216⟩
médecine/sciences, EDP Sciences, 2019, 35, pp.1083-1091. ⟨10.1051/medsci/2019216⟩
Monoclonal antibodies have revolutionized the treatment of many diseases, but their clinical effectiveness remains limited in some cases. Associations of antibodies binding to the same target (homo-combination) or to several different targets (hetero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::537ea71c454459f67a39d46e8a1b6397
https://hal.archives-ouvertes.fr/hal-02331499/document
https://hal.archives-ouvertes.fr/hal-02331499/document
Autor:
Clorennec, Christophe Le, Yassamine Lazrek, Dubreuil, Olivier, Sampaio, Carla, Larbouret, Christel, Lanotte, Romain, Marie-Alix Poul, Jean-Marc Barret, Jean-François Prost, Pèlegrin, André, Chardès, Thierry
Figure S1. (a) Flow cytometry analysis of EGFR, HER2 and HER3 expression at the membrane of BxPC3, DU-145 and MDA-MB-468 cells. (b) Western blot analysis of receptor and NRG1 expression, and USP8, USP9 and ITCH expression in whole lysates of BxPC3, D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b11d8f53a544332639236c0f1a3f1145